Evidence map›Paper›PMID 39274033›Full record

ArticlePolymers2024

Biomedical Composites of Polycaprolactone/Hydroxyapatite for Bioplotting: Comprehensive Interpretation of the Reinforcement Course.

Markos Petousis, Nikolaos Michailidis, Apostolos Korlos, Vassilis Papadakis, Constantine David, Dimitrios Sagris, Nikolaos Mountakis, Apostolos Argyros, John Valsamos, Nectarios Vidakis

Abstract read
In one paragraph

Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Markos PetousisDepartment of Mechanical Engineering, Hellenic Mediterranean University, 71410 Heraklion, Greece.ORCID 0000-0003-1312-7898
Nikolaos MichailidisPhysical Metallurgy Laboratory, Mechanical Engineering Department, School of Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0002-4291-5327
Apostolos KorlosDepartment of Industrial Engineering and Management, International Hellenic University, 14th km Thessaloniki-N. Moudania, Thermi, 57001 Thessaloniki, Greece.ORCID 0000-0003-3573-5405
Vassilis PapadakisDepartment of Industrial Design and Production Engineering, University of West Attica, 12243 Athens, Greece.ORCID 0000-0003-3188-4577
Constantine DavidDepartment of Mechanical Engineering, International Hellenic University, Serres Campus, 62124 Serres, Greece.ORCID 0000-0003-4515-0259
Dimitrios SagrisDepartment of Mechanical Engineering, International Hellenic University, Serres Campus, 62124 Serres, Greece.ORCID 0000-0003-2039-6535
Nikolaos MountakisDepartment of Mechanical Engineering, Hellenic Mediterranean University, 71410 Heraklion, Greece.ORCID 0000-0003-4509-8753
Apostolos ArgyrosPhysical Metallurgy Laboratory, Mechanical Engineering Department, School of Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0002-7982-7742
John ValsamosDepartment of Mechanical Engineering, Hellenic Mediterranean University, 71410 Heraklion, Greece.
Nectarios VidakisDepartment of Mechanical Engineering, Hellenic Mediterranean University, 71410 Heraklion, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robust materials in medical applications are sought after and researched, especially for 3D printing in bone tissue engineering. Poly[ε-caprolactone] (PCL) is a commonly used polymer for scaffolding and other medical uses. Its strength is a drawback compared to other polymers. Herein, PCL was mixed with hydroxyapatite (HAp). Composites were developed at various concentrations (0.0-8.0 wt. %, 2.0 step), aiming to enhance the strength of PCL with a biocompatible additive in bioplotting. Initially, pellets were derived from the shredding of filaments extruded after mixing PCL and HAp at predetermined quantities for each composite. Specimens were then manufactured by bioplotting 3D printing. The samples were tested for their thermal and rheological properties and were also mechanically, morphologically, and chemically examined. The mechanical properties included tensile and flexural investigations, while morphological and chemical examinations were carried out employing scanning electron microscopy and energy dispersive spectroscopy, respectively. The structure of the manufactured specimens was analyzed using micro-computed tomography with regard to both their dimensional deviations and voids. PCL/HAp 6.0 wt. % was the composite that showed the most enhanced mechanical (14.6% strength improvement) and structural properties, proving the efficiency of HAp as a reinforcement filler in medical applications.

Indexed as

fused filament fabrication (FFF)hydroxyapatite (HAp)micro-computed tomography (μCT)polycaprolactone (PCL)scanning electron microscopy (SEM)three-dimensional bio-plotting

Identifiers

PMID39274033
PMCPMC11396925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.